Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study

NCT01725490 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT01725490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01725490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study
Lead sponsor
Yonsei University
Phase
Phase 2
Overall status
Completed
Start date
February 15, 2013
Completion date
August 30, 2020
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial adenomatous polyposis